Key facts
- It has raised $2.5M; the latest was Early Stage VC in Jan 2026.
- Notable investors include J-Impact.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Epilog (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for Epilog (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Epilog (Clinics/Outpatient Services)
Operator of a patient-centric, holistic companion platform intended to offer navigation of complex medical journeys during the later stages of life. The company's platform leverages behavioral economics and digital engagement strategies to identify unmet needs, manage physical symptoms, and facilitate challenging conversations about care transitions, enabling patients and healthcare organizations to transition from reactive disease management to personalized, quality-of-life care that aligns with individual dignity and clinical goals.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2022
- Employees
- 7
- Website
- epilog.world/
- Ownership
- Privately Held (backing)
Epilog (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Epilog (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Epilog (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.